First Trust Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

First Trust Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-138,187	Closed	-$2.43M	–	309
2021 Q3	$2.43M	Buy	+138,187	New	+$1.61M	0.37%	60

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

First Trust Capital Management's TRIL Position: Q4 2021 in Review

First Trust Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 138,187 shares — an estimated $2.43M sold.

First Trust Capital Management first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $2.43M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

First Trust Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
First Trust Capital Management sold 138,187 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2.43M.
First Trust Capital Management first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
First Trust Capital Management's Trillium Therapeutics Inc. position peaked at $2.43M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on First Trust Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.